Franklin Resources Portfolio holdings
Franklin Resources is the parent of the Franklin Templeton fund brands, founded in 1947 by Rupert H. Johnson Sr., a Wall Street retail broker who named it after Benjamin Franklin. Rupert Sr.'s son Charles B. Johnson became president and chief executive in 1957, and the company went public in 1971. In 1992 Franklin bought Templeton, Galbraith & Hansberger, which was then owned by mutual fund pioneer Sir John Templeton, and in 2020 it bought Legg Mason. Its fund brands include Franklin for bond funds, Templeton for international funds and Mutual Series for value funds. Its funds include Templeton Growth, opened in 1954, Mutual Shares, opened in 1949, and Mutual Discovery, opened in 1992. It launched its first ETFs in 2013 and a bitcoin and ether ETF in 2025, and in August 2026 Franklin Resources renamed itself Franklin Templeton, Inc. to match its brand.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$332M |
| 2 |
Analog Devices
ADI
|
+$302M |
| 3 |
Pfizer
PFE
|
+$271M |
| 4 |
Halliburton
HAL
|
+$252M |
| 5 |
Voya Financial
VOYA
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.05B |
| 2 |
Johnson & Johnson
JNJ
|
+$767M |
| 3 |
AT&T
T
|
+$652M |
| 4 |
Exelon
EXC
|
+$612M |
| 5 |
PG&E
PCG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17% |
| 2 | Financials | 14.88% |
| 3 | Technology | 13.22% |
| 4 | Industrials | 11.16% |
| 5 | Energy | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.9T
| $4.8B | 2.55% |
86,943,774
-990,788
| -1% | -$51.9M |
2013 Q2
11 quarters
|
|
|
2
JPMorgan Chase
JPM
$915B
| $2.49B | 1.32% |
42,060,882
+5,685,864
| +16% | +$332M |
2013 Q2
11 quarters
|
|
3
Medtronic
MDT
$132B
| $2.43B | 1.29% |
32,415,877
-5,040,882
| -13% | -$380M |
2013 Q2
11 quarters
|
|
4
Merck
MRK
$364B
| $2.43B | 1.29% |
48,033,464
-2,029,658
| -4% | -$99.4M |
2013 Q2
11 quarters
|
|
5
Chevron
CVX
$427B
| $2.42B | 1.29% |
25,399,149
-1,106,629
| -4% | -$96.8M |
2013 Q2
11 quarters
|
|
|
RDS.A
6
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.4B | 1.28% |
52,326,158
+370,269
| +0.7% | +$15.7M |
2013 Q2
11 quarters
|
|
7
PepsiCo
PEP
$197B
| $2.12B | 1.13% |
20,702,897
-1,463,333
| -7% | -$145M |
2013 Q2
11 quarters
|
|
8
Eli Lilly
LLY
$1.29T
| $2B | 1.06% |
27,744,978
+961,204
| +4% | +$72.7M |
2013 Q2
11 quarters
|
|
9
Teva Pharmaceutical Industries Limited
TEVA
$51.4B
| $1.97B | 1.05% |
36,821,959
-4,140,536
| -10% | -$243M |
2013 Q2
11 quarters
|
|
10
Cisco
CSCO
$376B
| $1.96B | 1.04% |
68,832,423
+6,635,971
| +11% | +$171M |
2013 Q2
11 quarters
|
|
|
11
Pfizer
PFE
$164B
| $1.86B | 0.99% |
66,299,755
+9,491,383
| +17% | +$271M |
2013 Q2
11 quarters
|
|
12
RTX Corp
RTX
$267B
| $1.81B | 0.96% |
28,724,127
+466,586
| +2% | +$27.1M |
2013 Q2
11 quarters
|
|
13
GE Aerospace
GE
$343B
| $1.76B | 0.94% |
11,580,781
-993,428
| -8% | -$140M |
2013 Q2
11 quarters
|
|
14
Apple
AAPL
$5.19T
| $1.54B | 0.82% |
56,682,896
+6,904,056
| +14% | +$172M |
2013 Q2
11 quarters
|
|
15
Citigroup
C
$205B
| $1.49B | 0.79% |
35,703,059
+298,561
| +0.8% | +$12.5M |
2013 Q2
11 quarters
|
|
16
Wells Fargo
WFC
$257B
| $1.47B | 0.78% |
30,315,347
+5,111,581
| +20% | +$250M |
2013 Q2
11 quarters
|
|
17
Stryker
SYK
$117B
| $1.39B | 0.74% |
12,965,578
-725,364
| -5% | -$71.5M |
2013 Q2
11 quarters
|
|
18
Target
TGT
$73B
| $1.38B | 0.74% |
16,827,398
-4,179,422
| -20% | -$316M |
2013 Q2
11 quarters
|
|
19
Amgen
AMGN
$252B
| $1.36B | 0.72% |
9,091,245
-575,006
| -6% | -$85.4M |
2013 Q2
11 quarters
|
|
20
American International
AIG
$42.8B
| $1.36B | 0.72% |
25,111,520
-1,389,001
| -5% | -$75M |
2013 Q2
11 quarters
|
|
21
Gilead Sciences
GILD
$209B
| $1.31B | 0.7% |
14,291,028
-141,322
| -1% | -$12.7M |
2013 Q2
11 quarters
|
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $1.3B | 0.69% |
4,840,650
-332,350
| -6% | -$95.1M |
2013 Q2
11 quarters
|
|
23
General Motors
GM
$72.7B
| $1.25B | 0.66% |
39,745,374
+4,458,256
| +13% | +$134M |
2013 Q2
11 quarters
|
|
24
CVS Health
CVS
$113B
| $1.25B | 0.66% |
12,032,870
-833,584
| -6% | -$81.1M |
2013 Q2
11 quarters
|
|
25
DELISTED
Walgreens Boots Alliance
WBA
| $1.23B | 0.65% |
14,603,991
-111,217
| -0.8% | -$8.88M |
2013 Q2
11 quarters
|
|
Similar funds
Franklin Resources's Q1 2016 Portfolio in Review
As of Q1 2016, Franklin Resources held 1,610 positions worth $188B, down 4.6% from $198B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Franklin Resources withdrew a net $11.3B in Q1 2016, closing 106 positions and reducing 620 holdings. Its most notable exit was Broadcom, an estimated $269M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Franklin Resources opened a new position in CLECO CRP (HOLDING CO) worth $38.8M.
- Franklin Resources's largest Q1 2016 buy was CLECO CRP (HOLDING CO): 702,000 shares worth $38.8M.
- Franklin Resources added most to JPMorgan Chase in Q1 2016, an estimated $332M increase.
- Franklin Resources's biggest Q1 2016 reduction was ExxonMobil, cutting an estimated $1.05B.
- Franklin Resources fully exited Broadcom in Q1 2016, selling an estimated $269M.
- Franklin Resources's ten largest holdings make up 13% of its $188B portfolio in Q1 2016.
- Franklin Resources opened 46 new positions and closed 106 in Q1 2016.
- Franklin Resources's portfolio value fell 4.6% quarter-over-quarter to $188B.
Based on Franklin Resources's 13F filing for Q1 2016, filed 10 May 2016.